HER2-positive Advanced Breast Cancer Treatment in 2020

Approximately 15% to 20% of breast cancers are human epidermal growth factor receptor-positive (HER2-positive), which is associated with worse survival outcomes as compared to estrogen receptor (ER) positive, HER2-negative breast cancer. Over the last 30 years, the development of a number of anti-

Source: Cancer Treatment Reviews - May 20, 2020 Category: Cancer & Oncology Authors: Marcelle G Cesca, Lucas Vian, Sofia Crist óvão-Ferreira, Noam Pondé, Evandro de Azambuja Tags: Anti-tumour Treatment Source Type: research